[1] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [2] 张福奎,贾继东,王宝恩. 慢性乙型肝炎的治疗. 中华肝脏病杂志,2000,8 (4):253. [3] Liaw YF. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B:A review. Hepatology,2011,54(2):E1-9. [4] Brunetto MR,Moriconi F,Bonino F,et al. Hepatitis B virus surface antigen levels:a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology,2008,49:1141-1150. [5] Sung JJ,Tsoi KK,Li KC,et al. Meta-analysis:treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther,2008,28:1067-1077. [6] Chan HL,Wong VW,Wong GL,et al. Early hepatitis B virus DNA suppression can predict virological response to peginterferon and lamivudine treatment. Clin Gastroenterol Hepatol,2008,6:1022-1026. [7] Wong GL,Chan HL. Predictors of treatment response in chronic hepatitis B. Drug,2009,69:2167-2177. [8] Buster EH,Hansen BE,Lau GK,et al. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Gastroenterology,2009,137: 2002-2009. [9] Ter Borg MJ,Van Zonneveld M,Zeuzem S,et al. Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B:relation to treatment response. Hepatology,2006,44:721-727. [10] European Association for the Study of the Liver. EASL clinical practice guidelines:management of chronic hepatitis B. J Hepatol,2009,50: 227-242. [11] Arai M,Togo S,Kanda T,et al. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance. Eur J Gastroenterol Hepatol, 2012,[Epub ahead of print]. (校对:陈宗炳) |